James F. Young

4.3k total citations · 1 hit paper
46 papers, 3.4k citations indexed

About

James F. Young is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, James F. Young has authored 46 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 12 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in James F. Young's work include Influenza Virus Research Studies (17 papers), Respiratory viral infections research (17 papers) and Malaria Research and Control (8 papers). James F. Young is often cited by papers focused on Influenza Virus Research Studies (17 papers), Respiratory viral infections research (17 papers) and Malaria Research and Control (8 papers). James F. Young collaborates with scholars based in United States, Australia and United Kingdom. James F. Young's co-authors include Peter Palese, David S. Pfarr, Robert M. Woods, Syd Johnson, Mark Krystal, Wayne T. Hockmeyer, Nita Patel, Peter A. Kiener, Herren Wu and Gregory A. Prince and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

James F. Young

43 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

1997 513 citations Syd Johnson, Cynthia N. Oliver et al. The Journal of Infectious Diseases profile →

Peers

Countries citing papers authored by James F. Young

Since Specialization

Citations

This map shows the geographic impact of James F. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Young more than expected).

Fields of papers citing papers by James F. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Young. The network helps show where James F. Young may publish in the future.

Co-authorship network of co-authors of James F. Young

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Young. A scholar is included among the top collaborators of James F. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Young. James F. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID 2025 ·Viruses ·Swayam Prakash, (unknown), (unknown), Delia F. Tifrea, Cesar Figueroa, (unknown), James F. Young, Greg Glenn, (unknown), Trevor Jones, Robert Redfield, Lbachir BenMohamed	0
2	Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience 2019 ·Ophthalmology and Therapy ·James F. Young, Andrew Walkden, (unknown), Sajjad Mahmood	14
3	Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding Kinetics and Binding Valence on Viral Neutralization 2005 ·Journal of Molecular Biology ·Herren Wu, David S. Pfarr, Ying Tang, Ling–Ling An, Nita Patel, Jeffry D. Watkins, William D. Huse, Peter A. Kiener, James F. Young	151
4	A Direct Comparison of the Activities of Two Humanized Respiratory Syncytial Virus Monoclonal Antibodies: MEDI‐493 and RSHZl9 1999 ·The Journal of Infectious Diseases ·Syd Johnson, (unknown), David S. Pfarr, Michael L. Doyle, Robert M. Woods, David A Carlin, Gregory A. Prince, Scott Koenig, James F. Young, Susan B. Dillon	77
5	Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus breakdown → 1997 ·The Journal of Infectious Diseases ·Syd Johnson, Cynthia N. Oliver, Gregory A. Prince, Val G. Hemming, David S. Pfarr, (unknown), (unknown), J. E. O'GRADY, Scott Koenig, James Tamura, Robert M. Woods, Geetha P. Bansal, (unknown), Eric Tsao, William C. Hall, James F. Young	513
6	A MODIFICATION OF SINGLE STAPLED COLORECTAL ANASTOMOSIS USING THE TRANSANAL INSERTION DEVICE (TAIS) 1996 ·Australian and New Zealand Journal of Surgery ·D. C. Hoffmann, James F. Young, James L. Sweeney, (unknown), James W. Moore	3
7	The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine 1996 ·Neurology ·Roy Freeman, James F. Young, Lewis Landsberg, Lewis A. Lipsitz	25
8	Investigation of fecal incontinence with endoanal ultrasound 1996 ·Diseases of the Colon & Rectum ·Nicholas Rieger, James L. Sweeney, D. C. Hoffmann, James F. Young, (unknown)	37
9	Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant 1992 ·Vaccine ·Susan B. Dillon, (unknown), Mark Schneider, Cynthia Weston, Christopher S. Jones, James F. Young, Miller O. Scott, (unknown), (unknown), Nabil Hanna	42
10	The Development of Molecular Vaccines against Malaria Sporozoites 1989 ·PubMed ·W. Ripley Ballou, James F. Young, Stanley J. Cryz, Jerald Sadoff	1
11	Immunization of Saimiri Sciureus Boliviensis with Recombinant Vaccines Based on the Circumsporozoite Protein of Plasmodium Vivax 1989 ·American Journal of Tropical Medicine and Hygiene ·W. E. Collins, R S Nussenzweig, W R Ballou, Trenton K. Ruebush, Elizabeth Nardin, J D Chulay, William R. Majarian, James F. Young, (unknown), Ian Bathurst, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	47
12	Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes. 1989 ·The Journal of Experimental Medicine ·Koichi Kuwano, Miller O. Scott, James F. Young, Francis A. Ennis	28
13	Kinetics and Specificity at the Clonal Level of the Cytotoxic T Lymphocyte Response to Influenza Pneumonia 1987 ·Viral Immunology ·(unknown), Koichi Kuwano, Akio Yamada, Miller O. Scott, James F. Young, Francis A. Ennis	2
14	Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. 1985 ·The Journal of Experimental Medicine ·Akira Yamada, (unknown), James F. Young, Yasuko Yamada, Francis A. Ennis	48
15	Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli. 1985 ·The Journal of Experimental Medicine ·Akio Yamada, James F. Young, Francis A. Ennis	18
16	Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. 1983 ·Proceedings of the National Academy of Sciences ·James F. Young, Ulrich Desselberger, Peter Palese, B Ferguson, (unknown), Martin Rosenberg	83
17	Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. 1983 ·Proceedings of the National Academy of Sciences ·Mark Krystal, James F. Young, Peter Palese, Ian A. Wilson, J.J. Skehel, Don C. Wiley	93
18	Variation of Influenza A, B, and C Viruses 1982 ·Science ·Peter Palese, James F. Young	166
19	Comparative stability of physiological parameters during sustained anesthesia in rats. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·J Buelke-Sam, Joseph F. Holson, (unknown), James F. Young	119
20	Osteomalacia and celiac disease 1978 ·The American Journal of Medicine ·Gershon W. Hepner, Jenifer Jowsey, Claude D. Arnaud, (unknown), (unknown), Martin S. Roginsky, (unknown), James F. Young	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact